Strides Pharma Science reports consolidated net loss of Rs 162.56 crore in the September 2021 quarter
Sales decline 9.08% to Rs 721.47 crore
Net loss of Strides Pharma Science reported to Rs 162.56 crore in the quarter ended September 2021 as against net profit of Rs 80.95 crore during the previous quarter ended September 2020. Sales declined 9.08% to Rs 721.47 crore in the quarter ended September 2021 as against Rs 793.56 crore during the previous quarter ended September 2020. ParticularsQuarter EndedSep. 2021Sep. 2020% Var.Sales721.47793.56 -9 OPM %-5.1216.63 -PBDT-58.29122.75 PL PBT-114.8569.96 PL NP-162.5680.95 PLPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content